ASS1 and liver cancer: A lack of ASS1 expression or ASS1 downregulation is very common in cancer, including myxofibrosarcomas, breast cancer, malignant melanoma, liver cancer, prostate cancer, pancreatic cancer, renal cancer, and osteosarcomas [5–8].